InNexus Biotechnology, Inc.
IXSBF
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Net Income | 63.98% | 44.36% | 37.61% | -17.20% | 14.80% |
| Total Depreciation and Amortization | 9.47% | -27.05% | -31.61% | 259.47% | -45.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -59.33% | -24.69% | -2.54% | 46.55% | 147.57% |
| Change in Net Operating Assets | -85.96% | -1.01% | -40.42% | 208.07% | -60.57% |
| Cash from Operations | 52.57% | 87.12% | 76.10% | 88.09% | -269.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -47.85% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -111.72% | -- |
| Cash from Investing | -- | -- | -- | -109.91% | 100.46% |
| Total Debt Issued | -69.12% | -58.39% | -70.19% | -100.37% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -80.49% | -67.90% | -68.53% | -63.01% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,954.05% | 289.30% | 122.10% | -106.19% | 100.55% |